1.
J Endocrinol Invest
; 44(12): 2855-2856, 2021 Dec.
Article
in English
| MEDLINE
| ID: mdl-34215999
Subject(s)
COVID-19/complications , Deamino Arginine Vasopressin/administration & dosage , Diabetes Insipidus, Neurogenic , Hypophysitis/diagnosis , Magnetic Resonance Imaging/methods , Pituitary Gland/diagnostic imaging , Antidiuretic Agents/administration & dosage , COVID-19/blood , COVID-19/diagnosis , COVID-19/physiopathology , COVID-19/therapy , Diabetes Insipidus, Neurogenic/blood , Diabetes Insipidus, Neurogenic/etiology , Diabetes Insipidus, Neurogenic/physiopathology , Diabetes Insipidus, Neurogenic/therapy , Diagnosis, Differential , Female , Humans , Hypophysitis/physiopathology , Hypophysitis/virology , Middle Aged , SARS-CoV-2/isolation & purification , Treatment Outcome , Post-Acute COVID-19 Syndrome
2.
J Med Primatol
; 46(6): 364-367, 2017 12.
Article
in English
| MEDLINE
| ID: mdl-28671330
ABSTRACT
Rhesus macaques experimentally infected with Simian Immunodeficiency Virus (SIV) experience immunosuppression and often opportunistic infection. Among the most common opportunistic infections are rhesus cytomegalovirus (RhCMV), a ubiquitous betaherpesvirus that undergoes continuous low-level replication in immunocompetent monkeys. Upon SIV-mediated immunodeficiency, RhCMV reactivates and results in lesions in numerous organ systems including the nervous and reproductive systems. We report the first case of cytomegaloviral hypophysitis in a SIV-immunocompromised rhesus macaque.
